Fighting asthma drug resistance

January 10, 2014
Figure 1: Asthmatic airway inflammation in mice induced by IL-33 and TSLP (bright pink, left) cannot be reduced by steroid treatment (center) but can be reduced when steroid treatment is augmented by the STAT5 inhibitor pimozide (right). Credit: H. Kabata et al.

Current asthma treatments include drugs that open up the tubes of the lungs and corticosteroids that fight lung inflammation. Some patients, however, are stubbornly resistant to corticosteroids, limiting the therapies available to them. Shigeo Koyasu and Kazuyo Moro from the RIKEN Center for Integrative Medical Sciences, in collaboration with Hiroki Kabata of the Keio University School of Medicine and Koichiro Asano of Tokai University and co-workers, have now found that the inflammatory protein called thymic stromal lymphopoietin (TSLP) and its downstream signaling molecules play key roles in the resistance of natural helper (NH) immune cells, a member of group 2 innate lymoid cells (ILC2s), to the anti-inflammatory effects of corticosteroid treatment.

Asthma is a chronic disease of the airways characterized by persistent . The condition is known to be driven by the production of type 2 cytokines, such as interleukin (IL)-5 and IL-13, by NH cells.

The researchers developed a mouse model for this condition by administering an allergen and the pro-inflammatory cytokine IL-33 to mice. The treatment caused an increase in NH cells and mucus production in the lung, similar to the response observed in the lungs of asthmatic patients. Mice treated with corticosteroids did not show any improvement, indicating that the condition was resistant to the drug.

Koyasu and his colleagues found that the lungs of the mice that received the allergen and IL-33 also had higher levels of TSLP. Separately, they found that the addition of TSLP to NH cells cultured in the presence of IL-33 induced the proliferation of NH cells, even when corticosteroids were present. These findings suggest that TSLP causes NH cells to become resistant to the anti-inflammatory effects of treatment.

In other cell culture experiments the researchers found that in the absence of TSLP, NH cells died more readily under corticosteroid treatment, indicating that an antibody that blocks TSLP could eliminate corticosteroid resistance.

The team then discovered that in the presence of TSLP, NH cells activate the intracellular signaling protein STAT5. Pimozide, widely used as an anti-psychotic drug, is known to inhibit STAT5. Experiments confirmed that pimozide did indeed restore the susceptibility of NH to corticosteroids in cell culture (Fig. 1).

The research provides strong evidence that pimozide could be used to eliminate resistance to corticosteroids for the treatment of asthma. "Because pimozide has already been in clinical use for a while, this drug could be applied to patients with corticosteroid-resistant severe asthma after appropriate clinical studies are conducted," explains Koyasu.

Explore further: Hope of new treatment for severe asthma patients

More information: Kabata, H., Moro, K., Fukunaga, K., Suzuki, Y., Miyata, J., Masaki, K., Betsuyaku, T., Koyasu, S., & Asano, K. Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation. Nature Communications 4, 2675 (2013).

Related Stories

Hope of new treatment for severe asthma patients

October 25, 2013
New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids. In a study published today in the journal Nature Communications, researchers from the RIKEN Center for Integrative Medical ...

A treatment for obesity-associated asthma

December 16, 2013
(Medical Xpress)—Research conducted at Boston Children's Hospital indicates that obesity might cause asthma via factors in the immune system and suggests a new way of treating asthma in obese people—who often respond ...

Blocking nerve cells could prevent symptoms of eczema

October 3, 2013
A new picture of how the nervous system interacts with the immune system to cause the itch and inflammation associated with eczema, a chronic skin disease, could lead to new therapies for the condition, according to University ...

Mice at risk of asthma, allergies can fight off skin cancer

October 15, 2012
A molecule involved in asthma and allergies has now been shown to make mice resistant to skin cancer, according to scientists at Washington University School of Medicine in St. Louis.

Vitamin D analogs modulate immunity in psoriasis

March 9, 2012
(HealthDay) -- Vitamin D3 analogs modulate immunity in human psoriasis, inducing thymic stromal lymphopoietin (TSLP) and cathelicidin, according to a study published online March 2 in the British Journal of Dermatology.

Recommended for you

Targeting 'broken' metabolism in immune cells reduces inflammatory disease

July 12, 2017
The team, led by researchers at Imperial College London, Queen Mary University of London and Ergon Pharmaceuticals, believes the approach could offer new hope in the treatment of inflammatory conditions like arthritis, autoimmune ...

A perturbed skin microbiome can be 'contagious' and promote inflammation, study finds

June 29, 2017
Even in healthy individuals, the skin plays host to a menagerie of bacteria, fungi and viruses. Growing scientific evidence suggests that this lively community, collectively known as the skin microbiome, serves an important ...

Inflammatory bowel disease: Scientists zoom in on genetic culprits

June 28, 2017
Scientists have closed in on specific genes responsible for Inflammatory Bowel Disease (IBD) from a list of over 600 genes that were suspects for the disease. The team from the Wellcome Trust Sanger Institute and their collaborators ...

Trials show unique stem cells a potential asthma treatment

June 28, 2017
A study led by scientists at Monash University has shown that a new therapy developed through stem cell technology holds promise as a treatment for chronic asthma.

Researchers find piece in inflammatory disease puzzle

May 23, 2017
Inflammation is the process by which the body responds to injury or infection but when this process becomes out of control it can cause disease. Monash Biomedicine Discovery Institute (BDI) researchers, in collaboration with ...

Researchers reveal potential target for the treatment of skin inflammation in eczema and psoriasis

May 22, 2017
Superficially, psoriasis and atopic dermatitis may appear similar but their commonalities are only skin deep. Atopic dermatitis, also known as eczema, is primarily driven by an allergic reaction, while psoriasis is considered ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.